GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Filament Health Corp (OTCPK:FLHLF) » Definitions » EV-to-Revenue

FLHLF (Filament Health) EV-to-Revenue : 16.34 (As of May. 30, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Filament Health EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Filament Health's enterprise value is $4.89 Mil. Filament Health's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was $0.30 Mil. Therefore, Filament Health's EV-to-Revenue for today is 16.34.

The historical rank and industry rank for Filament Health's EV-to-Revenue or its related term are showing as below:

FLHLF' s EV-to-Revenue Range Over the Past 10 Years
Min: 3.15   Med: 23.2   Max: 129.37
Current: 16.34

During the past 5 years, the highest EV-to-Revenue of Filament Health was 129.37. The lowest was 3.15. And the median was 23.20.

FLHLF's EV-to-Revenue is ranked worse than
79.08% of 975 companies
in the Drug Manufacturers industry
Industry Median: 2.4 vs FLHLF: 16.34

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-05-30), Filament Health's stock price is $0.0201. Filament Health's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was $0.00. Therefore, Filament Health's PS Ratio for today is 20.10.


Filament Health EV-to-Revenue Historical Data

The historical data trend for Filament Health's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Filament Health EV-to-Revenue Chart

Filament Health Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-Revenue
- - 22.00 8.75 12.52

Filament Health Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.31 4.77 4.48 12.52 15.74

Competitive Comparison of Filament Health's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Filament Health's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Filament Health's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Filament Health's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Filament Health's EV-to-Revenue falls into.


;
;

Filament Health EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Filament Health's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=4.886/0.299
=16.34

Filament Health's current Enterprise Value is $4.89 Mil.
Filament Health's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.30 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Filament Health  (OTCPK:FLHLF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Filament Health's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.0201/0.001
=20.10

Filament Health's share price for today is $0.0201.
Filament Health's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Filament Health EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Filament Health's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Filament Health Business Description

Traded in Other Exchanges
Address
4475 Wayburne Drive, Unit 210, Burnaby, BC, CAN, V5G 4X4
Filament Health Corp is a natural psychedelic drug development company. Its mission is to see safe, approved, natural psychedelics in the hands of everyone who needs them as soon as possible. The group engages in natural extraction technology commercialization, utilizing its intellectual property portfolio, in-house GMP facility, and Health Canada psilocybin Dealer's License.

Filament Health Headlines